Results 121 to 130 of about 69,426 (314)

Computerized systems and databases for pharmacovigilance in Russia

open access: yesРеальная клиническая практика: данные и доказательства
The results of identifying new risks for pharmacovigilance systems and databases in Russia, including the Roszdravnadzor's web-based pharmacovigilance system, are presented.
B. K. Romanov   +4 more
doaj   +1 more source

Estimated Incidence of Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections Among Adults in Germany Between 2015 and 2019

open access: yesInfectious Diseases and Therapy
Introduction Respiratory syncytial virus (RSV) burden in adults is underestimated mainly due to unspecific symptoms and limited standard-of-care testing.
Aleksandra Polkowska-Kramek   +15 more
doaj   +1 more source

Pharmacovigilance: the evolution of drug safety monitoring

open access: yesJournal of Pharmaceutical Policy and Practice
The Pharmacovigilance system is aimed to promote and protect public health by ensuring the availability of essential medicines in the market and reducing the burden of ADRs. Pharmacovigilance is derived from two words; pharamakon rooted in the Greek word
Muhammad Akhtar Abbas Khan   +2 more
doaj   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen   +3 more
wiley   +1 more source

Assessment of pharmacovigilance knowledge and ADR reporting skills in undergraduate medical students using the OSPA model

open access: yesDialogues in Health
Background: Pharmacovigilance (PV) and adverse drug reaction (ADR) reporting are essential components of ensuring medication safety. However, many healthcare students have limited knowledge in these areas.
T.Y. Sree Sudha   +4 more
doaj   +1 more source

Injection‐site and dermatologic reactions associated with glucagon‐like peptide‐1 receptor agonists: Insights from meta‐analysis of randomised controlled trials and real‐world evidence

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are widely used for type 2 diabetes mellitus and obesity, with once‐weekly dosing that supports adherence. However, injection‐site reactions (ISRs) and dermatologic events have been recognised, ranging from mild local events to rare systemic hypersensitivity reactions that may cause ...
Shifa Taj   +6 more
wiley   +1 more source

A comparative analysis of three pharmacovigilance system assessment tools.

open access: yesPLoS ONE
BackgroundThree key tools are currently available for assessing pharmacovigilance systems at the national level: the Indicator-Based Pharmacovigilance Assessment Tool (IPAT), the World Health Organization (WHO) Pharmacovigilance Indicators, and the ...
Muhammad Akhtar Abbas Khan   +3 more
doaj   +1 more source

Evaluation and assessment of the knowledge, attitude and practice of pharmacy students with respect to pharmacovigilance in a Saudi pharmacy school: a cross-sectional study. [PDF]

open access: green, 2019
Ayesha Siddiqua   +10 more
openalex   +1 more source

Home - About - Disclaimer - Privacy